drugset / Trial / NCT06226402
Effect of Nebulized and Intravenous Hypertonic Saline 3% on the Management of Patients With Acute Respiratory Distress Syndrome
RandomizedParallel-groupSingle-blindTreatment
Summary
The aim of our study is to compare between the effect of nebulized and intravenous injection of hypertonic saline 3% on the outcome of patients with acute respiratory distress syndrome.
Timeline
- Start
- 2023-09-01
- Primary completion
- 2024-09-01
- Completion
- 2024-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hypertonic saline | Unknown | 3 % | Other |
| Subject | Hypertonic saline | Unknown | 5 ml | Other |